<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33730188</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-0428</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Diabetologia</Title>
          <ISOAbbreviation>Diabetologia</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Defining the underlying defect in insulin action in type 2 diabetes.</ArticleTitle>
        <Pagination>
          <StartPage>994</StartPage>
          <EndPage>1006</EndPage>
          <MedlinePgn>994-1006</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00125-021-05415-5</ELocationID>
        <Abstract>
          <AbstractText>Insulin resistance is one of the earliest defects in the pathogenesis of type 2 diabetes. Over the past 50 years, elucidation of the insulin signalling network has provided important mechanistic insights into the abnormalities of glucose, lipid and protein metabolism that underlie insulin resistance. In classical target tissues (liver, muscle and adipose tissue), insulin binding to its receptor initiates a broad signalling cascade mediated by changes in phosphorylation, gene expression and vesicular trafficking that result in increased nutrient utilisation and storage, and suppression of catabolic processes. Insulin receptors are also expressed in non-classical targets, such as the brain and endothelial cells, where it helps regulate appetite, energy expenditure, reproductive hormones, mood/behaviour and vascular function. Recent progress in cell biology and unbiased molecular profiling by mass spectrometry and DNA/RNA-sequencing has provided a unique opportunity to dissect the determinants of insulin resistance in type 2 diabetes and the metabolic syndrome; best studied are extrinsic factors, such as circulating lipids, amino acids and other metabolites and exosomal microRNAs. More challenging has been defining the cell-intrinsic factors programmed by genetics and epigenetics that underlie insulin resistance. In this regard, studies using human induced pluripotent stem cells and tissues point to cell-autonomous alterations in signalling super-networks, involving changes in phosphorylation and gene expression both inside and outside the canonical insulin signalling pathway. Understanding how these multi-layered molecular networks modulate insulin action and metabolism in different tissues will open new avenues for therapy and prevention of type 2 diabetes and its associated pathologies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Batista</LastName>
            <ForeName>Thiago M</ForeName>
            <Initials>TM</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haider</LastName>
            <ForeName>Nida</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kahn</LastName>
            <ForeName>C Ronald</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. c.ronald.kahn@joslin.harvard.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DK055545</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 DK036836</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK128429</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK121967</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R37 DK031036</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK031036</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK082659</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Diabetologia</MedlineTA>
        <NlmUniqueID>0006777</NlmUniqueID>
        <ISSNLinking>0012-186X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Diabetologia. 2022 Jun;65(6):1064</RefSource>
          <PMID Version="1">35320373</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Cell-autonomous</Keyword>
        <Keyword MajorTopicYN="Y">Insulin action</Keyword>
        <Keyword MajorTopicYN="Y">Insulin resistance</Keyword>
        <Keyword MajorTopicYN="Y">Phosphorylation</Keyword>
        <Keyword MajorTopicYN="Y">Review</Keyword>
        <Keyword MajorTopicYN="Y">The metabolic syndrome</Keyword>
        <Keyword MajorTopicYN="Y">Tissue crosstalk</Keyword>
        <Keyword MajorTopicYN="Y">Type 2 diabetes</Keyword>
        <Keyword MajorTopicYN="Y">iPS cells</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>17</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33730188</ArticleId>
        <ArticleId IdType="mid">NIHMS1783811</ArticleId>
        <ArticleId IdType="pmc">PMC8916220</ArticleId>
        <ArticleId IdType="doi">10.1007/s00125-021-05415-5</ArticleId>
        <ArticleId IdType="pii">10.1007/s00125-021-05415-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Macleod JJR (1922) Treatment of Diabetes Mellitus by Pancreatic Extracts. Can Med Assoc J
12(6): 425–426</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1524463</ArticleId>
            <ArticleId IdType="pubmed">20314142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himsworth HP (2013) Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. 1936. Int J Epidemiol
42(6): 1594–1598. 10.1093/ije/dyt203</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ije/dyt203</ArticleId>
            <ArticleId IdType="pubmed">24415598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freychet P, Roth J, Neville DM Jr. (1971) Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci U S A
68(8): 1833–1837. 10.1073/pnas.68.8.1833</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.68.8.1833</ArticleId>
            <ArticleId IdType="pmc">PMC389303</ArticleId>
            <ArticleId IdType="pubmed">4331561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR (1982) Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature
298(5875): 667–669. 10.1038/298667a0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/298667a0</ArticleId>
            <ArticleId IdType="pubmed">6178977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chevalier S, Burgess SC, Malloy CR, Gougeon R, Marliss EB, Morais JA (2006) The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes
55(3): 675–681. 10.2337/diabetes.55.03.06.db05-1117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.55.03.06.db05-1117</ArticleId>
            <ArticleId IdType="pubmed">16505230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry RJ, Camporez JP, Kursawe R, et al. (2015) Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell
160(4): 745–758. 10.1016/j.cell.2015.01.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.01.012</ArticleId>
            <ArticleId IdType="pmc">PMC4498261</ArticleId>
            <ArticleId IdType="pubmed">25662011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seino S, Seino M, Nishi S, Bell GI (1989) Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci U S A
86(1): 114–118. 10.1073/pnas.86.1.114</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.86.1.114</ArticleId>
            <ArticleId IdType="pmc">PMC286414</ArticleId>
            <ArticleId IdType="pubmed">2911561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belfiore A, Malaguarnera R, Vella V, et al. (2017) Insulin Receptor Isoforms in Physiology and Disease: An Updated View. Endocr Rev
38(5): 379–431. 10.1210/er.2017-00073</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2017-00073</ArticleId>
            <ArticleId IdType="pmc">PMC5629070</ArticleId>
            <ArticleId IdType="pubmed">28973479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai W, Sakaguchi M, Kleinridders A, et al. (2017) Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression. Nat Commun
8: 14892. 10.1038/ncomms14892</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms14892</ArticleId>
            <ArticleId IdType="pmc">PMC5378997</ArticleId>
            <ArticleId IdType="pubmed">28345670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urso B, Cope DL, Kalloo-Hosein HE, et al. (1999) Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J Biol Chem
274(43): 30864–30873. 10.1074/jbc.274.43.30864</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.274.43.30864</ArticleId>
            <ArticleId IdType="pubmed">10521479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scapin G, Dandey VP, Zhang Z, et al. (2018) Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature
556(7699): 122–125. 10.1038/nature26153</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature26153</ArticleId>
            <ArticleId IdType="pmc">PMC5886813</ArticleId>
            <ArticleId IdType="pubmed">29512653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uchikawa E, Choi E, Shang G, Yu H, Bai XC (2019) Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. eLife
8. 10.7554/eLife.48630</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.48630</ArticleId>
            <ArticleId IdType="pmc">PMC6721835</ArticleId>
            <ArticleId IdType="pubmed">31436533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thirone AC, Huang C, Klip A (2006) Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab
17(2): 72–78. 10.1016/j.tem.2006.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tem.2006.01.005</ArticleId>
            <ArticleId IdType="pubmed">16458527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Araki E, Lipes MA, Patti ME, et al. (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature
372(6502): 186–190. 10.1038/372186a0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/372186a0</ArticleId>
            <ArticleId IdType="pubmed">7526222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaburagi Y, Satoh S, Tamemoto H, et al. (1997) Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J Biol Chem
272(41): 25839–25844. 10.1074/jbc.272.41.25839</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.272.41.25839</ArticleId>
            <ArticleId IdType="pubmed">9325314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Withers DJ, Gutierrez JS, Towery H, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature
391(6670): 900–904. 10.1038/36116</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/36116</ArticleId>
            <ArticleId IdType="pubmed">9495343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabiee A, Kruger M, Ardenkjaer-Larsen J, Kahn CR, Emanuelli B (2018) Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action. Cell Signal
47: 1–15. 10.1016/j.cellsig.2018.03.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2018.03.003</ArticleId>
            <ArticleId IdType="pmc">PMC5951756</ArticleId>
            <ArticleId IdType="pubmed">29550500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ussar S, Bezy O, Bluher M, Kahn CR (2012) Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes
61(9): 2289–2298. 10.2337/db11-1395</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db11-1395</ArticleId>
            <ArticleId IdType="pmc">PMC3425403</ArticleId>
            <ArticleId IdType="pubmed">22751693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maddux BA, Goldfine ID (2000) Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes
49(1): 13–19. 10.2337/diabetes.49.1.13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.49.1.13</ArticleId>
            <ArticleId IdType="pubmed">10615944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batista TM, Dagdeviren S, Carroll SH, et al. (2020) Arrestin domain-containing 3 (Arrdc3) modulates insulin action and glucose metabolism in liver. Proc Natl Acad Sci U S A
117(12): 6733–6740. 10.1073/pnas.1922370117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1922370117</ArticleId>
            <ArticleId IdType="pmc">PMC7104271</ArticleId>
            <ArticleId IdType="pubmed">32156724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakaguchi M, Cai W, Wang CH, et al. (2019) FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism. Nat Commun
10(1): 1582. 10.1038/s41467-019-09418-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-019-09418-0</ArticleId>
            <ArticleId IdType="pmc">PMC6450906</ArticleId>
            <ArticleId IdType="pubmed">30952843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi E, Zhang X, Xing C, Yu H (2016) Mitotic Checkpoint Regulators Control Insulin Signaling and Metabolic Homeostasis. Cell
166(3): 567–581. 10.1016/j.cell.2016.05.074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.05.074</ArticleId>
            <ArticleId IdType="pmc">PMC5560052</ArticleId>
            <ArticleId IdType="pubmed">27374329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mora A, Komander D, van Aalten DM, Alessi DR (2004) PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol
15(2): 161–170. 10.1016/j.semcdb.2003.12.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2003.12.022</ArticleId>
            <ArticleId IdType="pubmed">15209375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol
20(9): 515–534. 10.1038/s41580-019-0129-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-019-0129-z</ArticleId>
            <ArticleId IdType="pubmed">31110302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning BD, Toker A (2017) AKT/PKB Signaling: Navigating the Network. Cell
169(3): 381–405. 10.1016/j.cell.2017.04.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2017.04.001</ArticleId>
            <ArticleId IdType="pmc">PMC5546324</ArticleId>
            <ArticleId IdType="pubmed">28431241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng J, Park J, Cron P, Hess D, Hemmings BA (2004) Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem
279(39): 41189–41196. 10.1074/jbc.M406731200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M406731200</ArticleId>
            <ArticleId IdType="pubmed">15262962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature
378(6559): 785–789. 10.1038/378785a0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/378785a0</ArticleId>
            <ArticleId IdType="pubmed">8524413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D (2007) Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab
6(3): 208–216. 10.1016/j.cmet.2007.08.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2007.08.006</ArticleId>
            <ArticleId IdType="pubmed">17767907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakae J, Barr V, Accili D (2000) Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J
19(5): 989–996. 10.1093/emboj/19.5.989</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/emboj/19.5.989</ArticleId>
            <ArticleId IdType="pmc">PMC305638</ArticleId>
            <ArticleId IdType="pubmed">10698940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neill BT, Lee KY, Klaus K, et al. (2016) Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. J Clin Invest
126(9): 3433–3446. 10.1172/JCI86522</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI86522</ArticleId>
            <ArticleId IdType="pmc">PMC5004956</ArticleId>
            <ArticleId IdType="pubmed">27525440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sancak Y, Thoreen CC, Peterson TR, et al. (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell
25(6): 903–915. 10.1016/j.molcel.2007.03.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2007.03.003</ArticleId>
            <ArticleId IdType="pubmed">17386266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J (2002) Tuberous sclerosis complex-1 and −2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A
99(21): 13571–13576. 10.1073/pnas.202476899</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.202476899</ArticleId>
            <ArticleId IdType="pmc">PMC129715</ArticleId>
            <ArticleId IdType="pubmed">12271141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, Wallberg-Henriksson H (2005) Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes
54(6): 1692–1697</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15919790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sano H, Kane S, Sano E, et al. (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem
278(17): 14599–14602. 10.1074/jbc.C300063200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.C300063200</ArticleId>
            <ArticleId IdType="pubmed">12637568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphrey SJ, Azimifar SB, Mann M (2015) High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics. Nat Biotechnol
33(9): 990–995. 10.1038/nbt.3327</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.3327</ArticleId>
            <ArticleId IdType="pubmed">26280412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphrey SJ, Yang G, Yang P, et al. (2013) Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab
17(6): 1009–1020. 10.1016/j.cmet.2013.04.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2013.04.010</ArticleId>
            <ArticleId IdType="pmc">PMC3690479</ArticleId>
            <ArticleId IdType="pubmed">23684622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batista TM, Garcia-Martin R, Cai W, et al. (2019) Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo. Cell reports
26(12): 3429–3443
 e3423. 10.1016/j.celrep.2019.02.081</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2019.02.081</ArticleId>
            <ArticleId IdType="pmc">PMC6543850</ArticleId>
            <ArticleId IdType="pubmed">30893613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlsson HK, Chibalin AV, Koistinen HA, et al. (2009) Kinetics of GLUT4 trafficking in rat and human skeletal muscle. Diabetes
58(4): 847–854. 10.2337/db08-1539</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db08-1539</ArticleId>
            <ArticleId IdType="pmc">PMC2661600</ArticleId>
            <ArticleId IdType="pubmed">19188436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruss MD, Arias EB, Lienhard GE, Cartee GD (2005) Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes
54(1): 41–50. 10.2337/diabetes.54.1.41</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.54.1.41</ArticleId>
            <ArticleId IdType="pubmed">15616009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang X, Vaag A, Hansson M, Weng J, Laurila E, Groop L (2000) Impaired insulin-stimulated expression of the glycogen synthase gene in skeletal muscle of type 2 diabetic patients is acquired rather than inherited. J Clin Endocrinol Metab
85(4): 1584–1590. 10.1210/jcem.85.4.6535</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.85.4.6535</ArticleId>
            <ArticleId IdType="pubmed">10770201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sears DD, Hsiao G, Hsiao A, et al. (2009) Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc Natl Acad Sci U S A
106(44): 18745–18750. 10.1073/pnas.0903032106</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0903032106</ArticleId>
            <ArticleId IdType="pmc">PMC2763882</ArticleId>
            <ArticleId IdType="pubmed">19841271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS (2003) Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A
100(13): 7996–8001. 10.1073/pnas.1332551100</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1332551100</ArticleId>
            <ArticleId IdType="pmc">PMC164701</ArticleId>
            <ArticleId IdType="pubmed">12808136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Brien RM, Granner DK (1991) Regulation of gene expression by insulin. Biochem J
278 (Pt 3): 609–619. 10.1042/bj2780609</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/bj2780609</ArticleId>
            <ArticleId IdType="pmc">PMC1151391</ArticleId>
            <ArticleId IdType="pubmed">1898350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunet A, Bonni A, Zigmond MJ, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell
96(6): 857–868</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10102273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol
21(3): 952–965. 10.1128/MCB.21.3.952-965.2001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.21.3.952-965.2001</ArticleId>
            <ArticleId IdType="pmc">PMC86685</ArticleId>
            <ArticleId IdType="pubmed">11154281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haeusler RA, Hartil K, Vaitheesvaran B, et al. (2014) Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun
5: 5190. 10.1038/ncomms6190</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms6190</ArticleId>
            <ArticleId IdType="pmc">PMC4197140</ArticleId>
            <ArticleId IdType="pubmed">25307742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandri M, Sandri C, Gilbert A, et al. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell
117(3): 399–412. 10.1016/s0092-8674(04)00400-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(04)00400-3</ArticleId>
            <ArticleId IdType="pmc">PMC3619734</ArticleId>
            <ArticleId IdType="pubmed">15109499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakae J, Cao Y, Oki M, et al. (2008) Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes
57(3): 563–576. 10.2337/db07-0698</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db07-0698</ArticleId>
            <ArticleId IdType="pubmed">18162510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>I OS, Zhang W, Wasserman DH, et al. (2015) FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun
6: 7079. 10.1038/ncomms8079</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms8079</ArticleId>
            <ArticleId IdType="pmc">PMC4755301</ArticleId>
            <ArticleId IdType="pubmed">25963540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu M, Wan M, Leavens KF, et al. (2012) Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med
18(3): 388–395. 10.1038/nm.2686</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2686</ArticleId>
            <ArticleId IdType="pmc">PMC3296881</ArticleId>
            <ArticleId IdType="pubmed">22344295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neill BT, Bhardwaj G, Penniman CM, et al. (2019) FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy. Diabetes
68(3): 556–570. 10.2337/db18-0416</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db18-0416</ArticleId>
            <ArticleId IdType="pmc">PMC6385751</ArticleId>
            <ArticleId IdType="pubmed">30523026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He L, Gomes AP, Wang X, et al. (2018) mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-Dependent Foxk1 Phosphorylation. Mol Cell
70(5): 949–960
 e944. 10.1016/j.molcel.2018.04.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2018.04.024</ArticleId>
            <ArticleId IdType="pmc">PMC6591025</ArticleId>
            <ArticleId IdType="pubmed">29861159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sukonina V, Ma H, Zhang W, et al. (2019) FOXK1 and FOXK2 regulate aerobic glycolysis. Nature
566(7743): 279–283. 10.1038/s41586-019-0900-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-019-0900-5</ArticleId>
            <ArticleId IdType="pubmed">30700909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimano H, Sato R (2017) SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol
13(12): 710–730. 10.1038/nrendo.2017.91</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrendo.2017.91</ArticleId>
            <ArticleId IdType="pubmed">28849786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldfine ID, Smith GJ (1976) Binding of insulin to isolated nuclei. Proc Natl Acad Sci U S A
73(5): 1427–1431. 10.1073/pnas.73.5.1427</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.73.5.1427</ArticleId>
            <ArticleId IdType="pmc">PMC430309</ArticleId>
            <ArticleId IdType="pubmed">179086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hancock ML, Meyer RC, Mistry M, et al. (2019) Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression. Cell
177(3): 722–736
 e722. 10.1016/j.cell.2019.02.030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2019.02.030</ArticleId>
            <ArticleId IdType="pmc">PMC6478446</ArticleId>
            <ArticleId IdType="pubmed">30955890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol
14(2): 88–98. 10.1038/nrendo.2017.151</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrendo.2017.151</ArticleId>
            <ArticleId IdType="pubmed">29219149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roden M, Shulman GI (2019) The integrative biology of type 2 diabetes. Nature
576(7785): 51–60. 10.1038/s41586-019-1797-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-019-1797-8</ArticleId>
            <ArticleId IdType="pubmed">31802013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaharia OP, Strassburger K, Strom A, et al. (2019) Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol
7(9): 684–694. 10.1016/S2213-8587(19)30187-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2213-8587(19)30187-1</ArticleId>
            <ArticleId IdType="pubmed">31345776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet
340(8825): 925–929</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1357346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med
321(6): 337–343. 10.1056/NEJM198908103210601</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM198908103210601</ArticleId>
            <ArticleId IdType="pubmed">2664520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothman DL, Magnusson I, Cline G, et al. (1995) Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A
92(4): 983–987</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC42621</ArticleId>
            <ArticleId IdType="pubmed">7862678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cline GW, Petersen KF, Krssak M, et al. (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med
341(4): 240–246. 10.1056/NEJM199907223410404</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199907223410404</ArticleId>
            <ArticleId IdType="pubmed">10413736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mootha VK, Lindgren CM, Eriksson KF, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet
34(3): 267–273. 10.1038/ng1180</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng1180</ArticleId>
            <ArticleId IdType="pubmed">12808457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patti ME, Butte AJ, Crunkhorn S, et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A
100(14): 8466–8471. 10.1073/pnas.1032913100</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1032913100</ArticleId>
            <ArticleId IdType="pmc">PMC166252</ArticleId>
            <ArticleId IdType="pubmed">12832613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gregor MF, Hotamisligil GS (2010) Inflammatory Mechanisms in Obesity. Annu Rev Immunol
29:415–445</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21219177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newgard CB (2012) Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab
15(5): 606–614. 10.1016/j.cmet.2012.01.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2012.01.024</ArticleId>
            <ArticleId IdType="pmc">PMC3695706</ArticleId>
            <ArticleId IdType="pubmed">22560213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell
148(5): 852–871. 10.1016/j.cell.2012.02.017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.02.017</ArticleId>
            <ArticleId IdType="pmc">PMC3294420</ArticleId>
            <ArticleId IdType="pubmed">22385956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunaif A, Xia J, Book CB, Schenker E, Tang Z (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest
96(2): 801–810. 10.1172/JCI118126</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI118126</ArticleId>
            <ArticleId IdType="pmc">PMC185266</ArticleId>
            <ArticleId IdType="pubmed">7635975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itani SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes
51(7): 2005–2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12086926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyu K, Zhang Y, Zhang D, et al. (2020) A Membrane-Bound Diacylglycerol Species Induces PKC-Mediated Hepatic Insulin Resistance. Cell Metab
32(4): 654–664
 e655. 10.1016/j.cmet.2020.08.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2020.08.001</ArticleId>
            <ArticleId IdType="pmc">PMC7544641</ArticleId>
            <ArticleId IdType="pubmed">32882164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moeschel K, Beck A, Weigert C, et al. (2004) Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1. J Biol Chem
279(24): 25157–25163. 10.1074/jbc.M402477200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M402477200</ArticleId>
            <ArticleId IdType="pubmed">15069075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weigert C, Hennige AM, Brischmann T, et al. (2005) The phosphorylation of Ser318 of insulin receptor substrate 1 is not per se inhibitory in skeletal muscle cells but is necessary to trigger the attenuation of the insulin-stimulated signal. J Biol Chem
280(45): 37393–37399</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16129678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paz K, Hemi R, LeRoith D, et al. (1997) A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem
272(47): 29911–29918. 10.1074/jbc.272.47.29911</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.272.47.29911</ArticleId>
            <ArticleId IdType="pubmed">9368067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glass CK, Olefsky JM (2012) Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab
15(5): 635–645. 10.1016/j.cmet.2012.04.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2012.04.001</ArticleId>
            <ArticleId IdType="pmc">PMC4156155</ArticleId>
            <ArticleId IdType="pubmed">22560216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson AM, Olefsky JM (2013) The origins and drivers of insulin resistance. Cell
152(4): 673–684. 10.1016/j.cell.2013.01.041</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2013.01.041</ArticleId>
            <ArticleId IdType="pubmed">23415219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun K, Kusminski CM, Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest
121(6): 2094–2101. 10.1172/JCI45887</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI45887</ArticleId>
            <ArticleId IdType="pmc">PMC3104761</ArticleId>
            <ArticleId IdType="pubmed">21633177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest
117(1): 175–184. 10.1172/JCI29881</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI29881</ArticleId>
            <ArticleId IdType="pmc">PMC1716210</ArticleId>
            <ArticleId IdType="pubmed">17200717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med
18(3): 363–374. 10.1038/nm.2627</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2627</ArticleId>
            <ArticleId IdType="pubmed">22395709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebrun P, Van Obberghen E (2008) SOCS proteins causing trouble in insulin action. Acta Physiol
192(1): 29–36. 10.1111/j.1748-1716.2007.01782.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1748-1716.2007.01782.x</ArticleId>
            <ArticleId IdType="pubmed">18171427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Ibi D, Taniguchi K, et al. (2016) Inflammation Improves Glucose Homeostasis through IKKbeta-XBP1s Interaction. Cell
167(4): 1052–1066
 e1018. 10.1016/j.cell.2016.10.015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.10.015</ArticleId>
            <ArticleId IdType="pmc">PMC5908236</ArticleId>
            <ArticleId IdType="pubmed">27814504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raciti M, Lotti LV, Valia S, Pulcinelli FM, Di Renzo L (2012) JNK2 is activated during ER stress and promotes cell survival. Cell death &amp; disease
3: e429. 10.1038/cddis.2012.167</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2012.167</ArticleId>
            <ArticleId IdType="pmc">PMC3542603</ArticleId>
            <ArticleId IdType="pubmed">23171849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings NE, Williams EM, Kasza I, et al. (2018) Restoration of metabolic health by decreased consumption of branched-chain amino acids. J Physiol
596(4): 623–645. 10.1113/JP275075</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/JP275075</ArticleId>
            <ArticleId IdType="pmc">PMC5813603</ArticleId>
            <ArticleId IdType="pubmed">29266268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newgard CB, An J, Bain JR, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab
9(4): 311–326. 10.1016/j.cmet.2009.02.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2009.02.002</ArticleId>
            <ArticleId IdType="pmc">PMC3640280</ArticleId>
            <ArticleId IdType="pubmed">19356713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saad MJ, Santos A, Prada PO (2016) Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology
31(4): 283–293. 10.1152/physiol.00041.2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physiol.00041.2015</ArticleId>
            <ArticleId IdType="pubmed">27252163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Copps KD, White MF (2012) Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia
55(10): 2565–2582. 10.1007/s00125-012-2644-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-012-2644-8</ArticleId>
            <ArticleId IdType="pmc">PMC4011499</ArticleId>
            <ArticleId IdType="pubmed">22869320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Vienberg SG, Bezy O, O’Neill BT, Kahn CR (2015) Role of PKCdelta in Insulin Sensitivity and Skeletal Muscle Metabolism. Diabetes
64(12): 4023–4032. 10.2337/db14-1891</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db14-1891</ArticleId>
            <ArticleId IdType="pmc">PMC4657586</ArticleId>
            <ArticleId IdType="pubmed">26307588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomou T, Mori MA, Dreyfuss JM, et al. (2017) Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature
542(7642): 450–455. 10.1038/nature21365</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature21365</ArticleId>
            <ArticleId IdType="pmc">PMC5330251</ArticleId>
            <ArticleId IdType="pubmed">28199304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying W, Riopel M, Bandyopadhyay G, et al. (2017) Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity. Cell
171(2): 372–384
 e312. 10.1016/j.cell.2017.08.035</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2017.08.035</ArticleId>
            <ArticleId IdType="pubmed">28942920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouzakri K, Roques M, Gual P, et al. (2003) Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes
52(6): 1319–1325</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12765939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cozzone D, Frojdo S, Disse E, et al. (2008) Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients. Diabetologia
51(3): 512–521. 10.1007/s00125-007-0913-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-007-0913-8</ArticleId>
            <ArticleId IdType="pubmed">18204829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaster M, Brusgaard K, Handberg A, Hojlund K, Wojtaszewski JF, Beck-Nielsen H (2004) The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3alpha activity in diabetic myotubes. Biochem Biophys Res Commun
319(4): 1235–1240. 10.1016/j.bbrc.2004.05.109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2004.05.109</ArticleId>
            <ArticleId IdType="pubmed">15194499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaster M, Petersen I, Hojlund K, Poulsen P, Beck-Nielsen H (2002) The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes
51(4): 921–927. 10.2337/diabetes.51.4.921</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.51.4.921</ArticleId>
            <ArticleId IdType="pubmed">11916908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McIntyre EA, Halse R, Yeaman SJ, Walker M (2004) Cultured muscle cells from insulin-resistant type 2 diabetes patients have impaired insulin, but normal 5-amino-4-imidazolecarboxamide riboside-stimulated, glucose uptake. J Clin Endocrinol Metab
89(7): 3440–3448. 10.1210/jc.2003-031919</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2003-031919</ArticleId>
            <ArticleId IdType="pubmed">15240629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burkart AM, Tan K, Warren L, et al. (2016) Insulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function. Scientific reports
6: 22788. 10.1038/srep22788</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep22788</ArticleId>
            <ArticleId IdType="pmc">PMC4780029</ArticleId>
            <ArticleId IdType="pubmed">26948272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iovino S, Burkart AM, Kriauciunas K, et al. (2014) Genetic insulin resistance is a potent regulator of gene expression and proliferation in human iPS cells. Diabetes
63(12): 4130–4142. 10.2337/db14-0109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db14-0109</ArticleId>
            <ArticleId IdType="pmc">PMC4238001</ArticleId>
            <ArticleId IdType="pubmed">25059784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iovino S, Burkart AM, Warren L, Patti ME, Kahn CR (2016) Myotubes derived from human-induced pluripotent stem cells mirror in vivo insulin resistance. Proc Natl Acad Sci U S A
113(7): 1889–1894. 10.1073/pnas.1525665113</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1525665113</ArticleId>
            <ArticleId IdType="pmc">PMC4763759</ArticleId>
            <ArticleId IdType="pubmed">26831110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta MK, Vethe H, Softic S, et al. (2020) Leptin Receptor Signaling Regulates Protein Synthesis Pathways and Neuronal Differentiation in Pluripotent Stem Cells. Stem cell reports
15(5): 1067–1079. 10.1016/j.stemcr.2020.10.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2020.10.001</ArticleId>
            <ArticleId IdType="pmc">PMC7664055</ArticleId>
            <ArticleId IdType="pubmed">33125875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teo AK, Windmueller R, Johansson BB, et al. (2013) Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young. J Biol Chem
288(8): 5353–5356. 10.1074/jbc.C112.428979</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.C112.428979</ArticleId>
            <ArticleId IdType="pmc">PMC3581399</ArticleId>
            <ArticleId IdType="pubmed">23306198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batista TM, Jayavelu AK, Wewer Albrechtsen NJ, et al. (2020) A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes. Cell Metab
32:844–859. 10.1016/j.cmet.2020.08.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2020.08.007</ArticleId>
            <ArticleId IdType="pmc">PMC7875546</ArticleId>
            <ArticleId IdType="pubmed">32888406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol
7(2): 85–96</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16493415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barres R, Osler ME, Yan J, et al. (2009) Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab
10(3): 189–198. 10.1016/j.cmet.2009.07.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2009.07.011</ArticleId>
            <ArticleId IdType="pubmed">19723495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribel-Madsen R, Fraga MF, Jacobsen S, et al. (2012) Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One
7(12): e51302. 10.1371/journal.pone.0051302</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0051302</ArticleId>
            <ArticleId IdType="pmc">PMC3519577</ArticleId>
            <ArticleId IdType="pubmed">23251491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frobel J, Hemeda H, Lenz M, et al. (2014) Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem cell reports
3(3): 414–422. 10.1016/j.stemcr.2014.07.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2014.07.003</ArticleId>
            <ArticleId IdType="pmc">PMC4266008</ArticleId>
            <ArticleId IdType="pubmed">25241740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vujkovic M, Keaton JM, Lynch JA, et al. (2020) Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet
52(7): 680–691. 10.1038/s41588-020-0637-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41588-020-0637-y</ArticleId>
            <ArticleId IdType="pmc">PMC7343592</ArticleId>
            <ArticleId IdType="pubmed">32541925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miguel-Escalada I, Bonas-Guarch S, Cebola I, et al. (2019) Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes. Nat Genet
51(7): 1137–1148. 10.1038/s41588-019-0457-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41588-019-0457-0</ArticleId>
            <ArticleId IdType="pmc">PMC6640048</ArticleId>
            <ArticleId IdType="pubmed">31253982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams K, Ingerslev LR, Bork-Jensen J, et al. (2020) Skeletal muscle enhancer interactions identify genes controlling whole-body metabolism. Nat Commun
11(1): 2695. 10.1038/s41467-020-16537-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-020-16537-6</ArticleId>
            <ArticleId IdType="pmc">PMC7264154</ArticleId>
            <ArticleId IdType="pubmed">32483258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Claussnitzer M, Dankel SN, Kim KH, et al. (2015) FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N Engl J Med
373(10): 895–907. 10.1056/NEJMoa1502214</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1502214</ArticleId>
            <ArticleId IdType="pmc">PMC4959911</ArticleId>
            <ArticleId IdType="pubmed">26287746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning AK, Hivert MF, Scott RA, et al. (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet
44(6): 659–669. 10.1038/ng.2274</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.2274</ArticleId>
            <ArticleId IdType="pmc">PMC3613127</ArticleId>
            <ArticleId IdType="pubmed">22581228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nigi L, Grieco GE, Ventriglia G, et al. (2018) MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes. International journal of molecular sciences
19(12):3705. 10.3390/ijms19123705</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19123705</ArticleId>
            <ArticleId IdType="pmc">PMC6321520</ArticleId>
            <ArticleId IdType="pubmed">30469501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massart J, Sjogren RJO, Lundell LS, et al. (2017) Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle. Diabetes
66(7): 1807–1818. 10.2337/db17-0141</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db17-0141</ArticleId>
            <ArticleId IdType="pubmed">28404597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katayama M, Wiklander OPB, Fritz T, et al. (2018) Circulating Exosomal miR-20b-5p is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle. Diabetes
68(3):515–526. 10.2337/db18-0470</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db18-0470</ArticleId>
            <ArticleId IdType="pubmed">30552111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henriksen TI, Davidsen PK, Pedersen M, et al. (2017) Dysregulation of a novel miR-23b/27b-p53 axis impairs muscle stem cell differentiation of humans with type 2 diabetes. Mol Metab
6(7): 770–779. 10.1016/j.molmet.2017.04.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmet.2017.04.006</ArticleId>
            <ArticleId IdType="pmc">PMC5485225</ArticleId>
            <ArticleId IdType="pubmed">28702332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang L, Li P, Yang W, et al. (2016) Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators. Cell Metab
24(4): 627–639. 10.1016/j.cmet.2016.08.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2016.08.019</ArticleId>
            <ArticleId IdType="pmc">PMC5181118</ArticleId>
            <ArticleId IdType="pubmed">27667668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carter G, Miladinovic B, Patel AA, Deland L, Mastorides S, Patel NA (2015) Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA Clin
4: 102–107. 10.1016/j.bbacli.2015.09.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbacli.2015.09.001</ArticleId>
            <ArticleId IdType="pmc">PMC4661729</ArticleId>
            <ArticleId IdType="pubmed">26675493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Parag S, Patel R, et al. (2019) Stabilization of lncRNA GAS5 by a Small Molecule and Its Implications in Diabetic Adipocytes. Cell
Chem Biol
26(3): 319–330
 e316. 10.1016/j.chembiol.2018.11.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chembiol.2018.11.012</ArticleId>
            <ArticleId IdType="pubmed">30661991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pihlajamaki J, Lerin C, Itkonen P, et al. (2011) Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab
14(2): 208–218. 10.1016/j.cmet.2011.06.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2011.06.007</ArticleId>
            <ArticleId IdType="pmc">PMC3167228</ArticleId>
            <ArticleId IdType="pubmed">21803291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weyer C, Funahashi T, Tanaka S, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab
86(5): 1930–1935. 10.1210/jcem.86.5.7463</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.86.5.7463</ArticleId>
            <ArticleId IdType="pubmed">11344187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lynes MD, Leiria LO, Lundh M, et al. (2017) The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med
23(5): 631–637. 10.1038/nm.4297</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.4297</ArticleId>
            <ArticleId IdType="pmc">PMC5699924</ArticleId>
            <ArticleId IdType="pubmed">28346411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yore MM, Syed I, Moraes-Vieira PM, et al. (2014) Discovery of a Class of Endogenous Mammalian Lipids with Anti-Diabetic and Anti-inflammatory Effects. Cell
159(2): 318–332</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4260972</ArticleId>
            <ArticleId IdType="pubmed">25303528</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
